StockClub

LGNDZ

LGNDZLigand Pharmaceuticals, Inc.$ --
Ligand Pharmaceuticals, Inc.

Ligand Pharmaceuticals, Inc.

LGNDZ

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
60M USD
YoY +39.4%
Operating Income
20M USD
YoY +155.5%
Net Income
45M USD
YoY +244.1%
EPS
2.27$
YoY +233.5%

Revenue

$268.1M
FY2024 Q1$31M
$31M
Q1
FY2024 Q2$72.5M
$72.5M
Q2
FY2024 Q3$124.3M
$124.3M
Q3
FY2024 Q4$167.1M
$167.1M
Q4
FY2025 Q1$45.3M
$45.3M
Q1
FY2025 Q2$93M
$93M
Q2
FY2025 Q3$208.4M
$208.4M
Q3
FY2025 Q4$268.1M
$268.1M
Q4
Actual
+$101M (+60.4%)

Net Income

$124.5M
FY2024 Q1$86.1M
$86.1M
Q1
FY2024 Q2$34.2M
$34.2M
Q2
FY2024 Q3$27.1M
$27.1M
Q3
FY2024 Q4$-4M
$-4M
Q4
FY2025 Q1$-42.5M
$-42.5M
Q1
FY2025 Q2$-37.6M
$-37.6M
Q2
FY2025 Q3$79.7M
$79.7M
Q3
FY2025 Q4$124.5M
$124.5M
Q4
Actual
+$128.5M (+3186.6%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$186.4M
Est:$173.1M
FY2020BEAT
$186.4M
FY2021MISS
Actual:$241.5M
Est:$269.8M
FY2021MISS
$241.5M
FY2022MISS
Actual:$196.2M
Est:$204M
FY2022MISS
$196.2M
FY2023BEAT
Actual:$131.3M
Est:$128.9M
FY2023BEAT
$131.3M
FY2024BEAT
Actual:$167.1M
Est:$163.4M
FY2024BEAT
$167.1M
FY2025BEAT
Actual:$268.1M
Est:$264M
FY2025BEAT
$268.1M

Analyst Estimates